Search clinical trials for: Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
Total 7 results
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingThe Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy SubjectsSARS-CoV-2 | PreventionChina
-
Sinocelltech Ltd.RecruitingCovid19United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru
-
Chulalongkorn UniversityRamathibodi Hospital; Ministry of Health, Thailand; The Government Pharmaceutical... and other collaboratorsCompletedSARS-CoV-2 Acute Respiratory Disease | SARS CoV 2 InfectionThailand
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
NovavaxNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia and other conditionsUnited States